Laurie Toich, Assistant Editor

Biosimilar costs 15% less than the reference product.

Switching from Remicade to Inflectra was not observed to impact Crohn’s disease treatment.

Top news of the day from across the healthcare landscape.

Researchers worked to develop a new statement for the prevention, management, and treatment of diabetic neuropathy.

Proposed rule would improve individual and small group health insurance options.

HR 1038 would prohibit pharmacy benefit managers from charging direct and indirect remuneration fees.

Study finds more stringent data on efficacy should be collected in drug development.

Improving Transparency and Accuracy in Medicare Part D Drug Spending Act would have a significant impact on pharmacy benefit managers.

Moving from preclinical to clinical testing should incorporate efficacy data.

Diabetes may develop or worsen with early-stage pancreatic cancer.

Premature death rates are declining among some minority populations, but increasing among whites, and American Indian/Alaska natives.

More patients treated with baricitinib achieved ACR50 and ACR70 compared with Humira.

EPOCH clinical trial stopped due to the inefficacy of an investigational Alzheimer’s disease drug.

Top news of the day from across the healthcare landscape.

Community Oncology Alliance at odds with the opinion of pharmacy benefit managers regarding direct and indirect remuneration fees.

Stakeholders debate the benefits of direct and indirect remuneration fees.

Exposure to pollution from motor vehicles and power plants linked to an increased risk of developing dementia.

Probenecid was found to reduce the symptoms of opioid misuse disorder.

Adding bezlotoxumab to C. difficile treatment reduce recurrent infections nearly 40%.

Certain BRCA1 mutations reduce the risk of developing leukemia.

Top news of the day from across the healthcare landscape.

Patients seeking treatment with the same drugs may face different out-of-pocket costs.

AXS-05 may treat patients with treatment-resistant depression.

Research indicates hepatitis C virus is linked to cancers other than hepatocellular carcinoma and non-Hodgkin lymphoma.

Liver injury reported in patients with oral multiple sclerosis drug.

New findings suggest that hepatitis C may cause cancers other than hepatocellular carcinoma and non-Hodgkin lymphoma.

The Cleveland Clinic received multi-million dollar awards to further multiple sclerosis and bone marrow failure syndrome research.

Top news of the day from across the healthcare landscape.

Direct and indirect remuneration fees may not harm patients as recent reports have stated.

PCMA states that direct and indirect remuneration fees are mischaracterized.